Cargando...

Mechanisms of Resistance to PARP Inhibitors—Three and Counting

Given the malleable nature of cancer cells, we should expect, and do see, the development of resistance to any new chemotherapeutic agent. Models that help us understand how this happens are a first step to better and more effective chemotherapeutics.

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Discov
Autores principales: Fojo, Tito, Bates, Susan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936267/
https://ncbi.nlm.nih.gov/pubmed/23319766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0514
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!